Camilo Alberto Dominguez Dominguez

Emailcamilo.dominguezurosario.educo

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Camilo Alberto Dominguez Dominguez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

1 Finished

Adverse reactions to medications as a reason for admission to the Emergency Room (SALEM)
Calderon Ospina, C. A. & Dominguez Dominguez, C. A.
9/1/12 → 12/31/20
Project: Research/Creation Project

6 Article
1 Chapter (peer-reviewed)
1 Review article

Genetic and molecular aspects of drug-induced QT interval prolongation
Baracaldo-Santamaría, D., Llinás-Caballero, K., Corso-Ramirez, J. M., Restrepo, C. M., Dominguez-Dominguez, C. A., Fonseca-Mendoza, D. J. & Calderon - Ospina, C. A., Jul 28 2021, In: International Journal of Molecular Sciences. 22, 15, 8090.
Research output: Contribution to journal › Review article › peer-review

Open Access
File
11 Scopus citations

5 Downloads (Pure)
Caso Clínico: Bradicardia desencadenada por propafenona
Calderon Ospina, C. A. & Dominguez Dominguez, C. A., 2018, In: Pharmaceutical Care Espana. 20, 1, p. 72 77 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Simulación
Translated title of the contribution: SimulationDominguez Dominguez, C. A. & Bustos Martinez, Y. F., Jan 1 2018, CEDIEL SEMIOLOGIA MEDICA. 8 ed. Bogotá: Editorial Médica Celsus, p. 51 55 p.
Research output: Chapter in Book/Report/Conference proceeding › Chapter (peer-reviewed) › peer-review
Sinus bradycardia and congestive heart failure: case report
Calderon Ospina, C. A. & Dominguez Dominguez, C. A., Jun 2 2018, In: Reactions. 20, 1, p. 72-77
Research output: Contribution to journal › Article › peer-review
Toxicidad neurológica asociada a la fenitoína en un paciente metabolizador intermedio para la enzima CYP2C19: Neurological toxicity associated with phenytoin in an intermediate metabolizer patient for CYP2C9 enzyme
Calderon Ospina, C. A., Dominguez Dominguez, C. A. & Aristizabal Gutierrez, F. A., 2018, In: Pharmaceutical Care Espana. 20, 3, p. 228 235 p., 3.
Research output: Contribution to journal › Article › peer-review

Camilo Alberto Dominguez Dominguez, Esp

Fingerprint

Network

Dive into details

Adverse reactions to medications as a reason for admission to the Emergency Room (SALEM)

Genetic and molecular aspects of drug-induced QT interval prolongation

Caso Clínico: Bradicardia desencadenada por propafenona

Simulación

Sinus bradycardia and congestive heart failure: case report

Toxicidad neurológica asociada a la fenitoína en un paciente metabolizador intermedio para la enzima CYP2C19: Neurological toxicity associated with phenytoin in an intermediate metabolizer patient for CYP2C9 enzyme

Camilo Alberto Dominguez Dominguez, Esp

Fingerprint

Network

Projects

Adverse reactions to medications as a reason for admission to the Emergency Room (SALEM)

Research output

Genetic and molecular aspects of drug-induced QT interval prolongation

Caso Clínico: Bradicardia desencadenada por propafenona

Simulación

Sinus bradycardia and congestive heart failure: case report

Toxicidad neurológica asociada a la fenitoína en un paciente metabolizador intermedio para la enzima CYP2C19: Neurological toxicity associated with phenytoin in an intermediate metabolizer patient for CYP2C9 enzyme